Oncology Research Open Access
Home Oncology Research All Issues Volume 34 Issue 1
Volume 34 Issue 1, December 2026
Review | Open Access
The Efficacy and Safety of B-Cell Maturation Antigen (BCMA) Antibody-Drug Conjugates (ADC) in Development against Cancer: A Systematic Review
Published: 30 December 2025
2026, 34(1): 1
Review | Open Access
The Role of Exosomes as a Key Factor of Cytostatic Resistance in Cancer: Mechanisms of Action, Potential Biomarkers, and Possible Exosome-Based Therapies
Published: 30 December 2025
2026, 34(1): 2
Review | Open Access
Effectiveness and Safety of Lenvatinib and Everolimus after Immune Checkpoint Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review
Published: 30 December 2025
2026, 34(1): 3
Review | Open Access
Circulating Tumor DNA in Cervical Cancer: Clinical Utility and Medico-Legal Perspectives
Published: 30 December 2025
2026, 34(1): 4
Review | Open Access
RP11-Derived Long Non-Coding RNAs in Hepatocellular Carcinoma: Hidden Treasures in Plain Sight
Published: 30 December 2025
2026, 34(1): 5
Review | Open Access
Male Breast Cancer: Epidemiology, Diagnosis, Molecular Mechanisms, Therapeutics, and Future Prospective
Published: 30 December 2025
2026, 34(1): 7
Review | Open Access
Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics
Published: 30 December 2025
2026, 34(1): 8
Review | Open Access
Branched-Chain Amino Acid Metabolic Reprogramming and Cancer: Molecular Mechanisms, Immune Regulation, and Precision Targeting
Published: 30 December 2025
2026, 34(1): 9
Article | Open Access
Real-World Outcomes of First-Line Palbociclib Plus Endocrine Therapy for HR+/HER2− Metastatic Breast Cancer in Japan: A Single-Center Retrospective Study
Published: 30 December 2025
2026, 34(1): 11
Article | Open Access
PNP as a Metabolic and Prognostic Driver of Breast Cancer Aggressiveness: Insights from Patient Tissue and Cell Models
Published: 30 December 2025
2026, 34(1): 13
Article | Open Access
P2RX1 Influences the Prognosis of Ph+/Ph-Like ALL through Energy and Calcium Metabolism
Published: 30 December 2025
2026, 34(1): 14
Article | Open Access
ZMIZ2/MCM3 Axis Participates in Triple-Negative Breast Cancer Progression
Published: 30 December 2025
2026, 34(1): 15
Article | Open Access
CBX4 Drives Gastric Cancer Progression by Activating β-Catenin Signaling
Published: 30 December 2025
2026, 34(1): 16
Article | Open Access
CSRNP1 Promotes Apoptosis and Mitochondrial Dysfunction via ROS-Mediated JNK/p38 MAPK Pathway Activation in Hepatocellular Carcinoma
Published: 30 December 2025
2026, 34(1): 17
Article | Open Access
HE4 Might Participate in Extracellular Matrix Remodeling in Ovarian Cancer via Activation of Fibroblasts
Published: 30 December 2025
2026, 34(1): 18
Article | Open Access
Pan-Cancer Analysis of Enhancer-Induced PAN3-AS1 and Experimental Validation as a WFDC13-Promoting Factor in Colon Cancer
Published: 30 December 2025
2026, 34(1): 19
Article | Open Access
Application Value and Research Frontiers of Immunotherapy in Glioblastoma: A Bibliometric and Visualized Analysis
Published: 30 December 2025
2026, 34(1): 20
Article | Open Access
ELK4 Promotes Vasculogenic Mimicry in Oral Squamous Cell Carcinoma via Driving DHFR Transcriptional Activation
Published: 30 December 2025
2026, 34(1): 21
Article | Open Access
Integrative Multi-Omics Analysis and Experiments Validation Identify COX5B as a Novel Therapeutic Target for Lung Adenocarcinoma
Published: 30 December 2025
2026, 34(1): 22
Article | Open Access
Development of Patient-Derived Conditionally Reprogrammed 3D Breast Cancer Culture Models for Drug Sensitivity Evaluation
Published: 30 December 2025
2026, 34(1): 23
Article | Open Access
STC2+ Malignant Cell State Associated with EMT, Tumor Microenvironment Remodeling, and Poor Prognosis Revealed by Single-Cell and Spatial Transcriptomics in Colorectal Cancer
Published: 30 December 2025
2026, 34(1): 24
Article | Open Access
ETV4-Mediated PD-L1 Upregulation Promotes Immune Evasion and Predicts Poor Immunotherapy Response in Melanoma
Published: 30 December 2025
2026, 34(1): 25
Article | Open Access
miR-512-3p/RPS6KA2 Axis Regulates Cisplatin Resistance in Ovarian Cancer via Autophagy and Ferroptosis
Published: 30 December 2025
2026, 34(1): 26
Article | Open Access
AGPAT3 Regulates Immune Microenvironment in Osteosarcoma via Lysophosphatidic Acid Metabolism
Published: 30 December 2025
2026, 34(1): 27
Retraction | Open Access
Retraction: Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133+ Ovarian Cancer Stem Cells
Published: 30 December 2025
2026, 34(1): 28
Retraction | Open Access
Retraction: MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells
Published: 30 December 2025
2026, 34(1): 29
Retraction | Open Access
Retraction: MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase
Published: 30 December 2025
2026, 34(1): 30